Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Therapeutic options and treatment of muscle invasive bladder cancer. Expert Rev Anticancer Ther 2001 Dec;1(4):511-22

Date

07/13/2002

Pubmed ID

12113083

DOI

10.1586/14737140.1.4.511

Scopus ID

2-s2.0-0035558069 (requires institutional sign-in at Scopus site)   8 Citations

Abstract

Carcinoma of the bladder is the second most common genitourinary malignancy. Although several treatments exist, the gold standard therapy for muscle invasive bladder cancer (> or = stage T2) is cystectomy with urinary diversion. We review various surgical treatments for muscle invasive bladder cancer, focusing on the reported survival rates, complications, advantages and disadvantages of each therapeutic modality.

Author List

O'Connor RC, Alsikafi NF, Steinberg GD

Author

Robert Corey O'Connor MD Professor in the Urologic Surgery department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Chemotherapy, Adjuvant
Cystectomy
Humans
Muscle Neoplasms
Neoadjuvant Therapy
Neoplasm Invasiveness
Radiotherapy, Adjuvant
Survival Rate
Treatment Outcome
Urinary Bladder Neoplasms
Urinary Diversion